NCT05865132View on ClinicalTrials.gov

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 6, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Esophagus Squamous Cell Carcinoma
Interventions
DRUG

Palbociclib

120mg/125mg po qd on day 1 to 21, every 28 days

DRUG

Afatinib

30mg/40mg po qd on day 1 to 28, every 28 days

Trial Locations (1)

Unknown

RECRUITING

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

AIPING ZHOU

OTHER